March/April, 2011, Vol. 11, Num. 2
Epilepsy Currents, March/April, 2011, Vol. 11, Num. 2
Table of Contents
Clinical Science - Current Review
Explaining the Unexplained; Expecting the Unexpected:Where Are We With Sudden Unexpected Death in Epilepsy?
Elizabeth J. Donner, MD, FRCPC
Clinical Science - Current Literature
Brand Spanking? The Presumptive Risks of Generic Antiepileptic Drugs
Scott Mintzer, MD
Interpreting Seizure Counts After Temporal Lobectomy:Not Just One-Two-Three
Warren T. Blume, M.D.
Is Depression a Risk Factor of Worse Response to Therapy in Epilepsy?
Andres M. Kanner, MD
Basic Science - Current Review
Revisiting AMPA Receptors as an Antiepileptic Drug Target
Michael A. Rogawski
Basic Science - Current Literature
A Persistent Little Current With a Big Impact on Epileptic Firing
Carl E. Stafstrom, MD, PhD
Rapamycin for Treatment of Epilepsy: Antiseizure, Antiepileptogenic, Both, or Neither?
Michael Wong, MD, PhD